Oct 29, 2026 earnings call — Propel AI rollout and Q3 performance
WTW delivered 4% organic growth, 150 basis points adjusted operating margin expansion, and 18% adjusted EPS growth.
Revenue $2.5B (est $2.5B) · EPS $3.63 (est $3.59)
Key quotes
"Among the many benefits of Propel and our broader technology investments are the opportunities they create to differentiate our businesses, strengthen our client value proposition, and drive growth."
"Health grew 6% organically with growth across all the regions."
"R&B grew 5% organically, led by our North American international regions as our strategy continues to drive growth, especially in our global specialty lines."
Analyst Q&A 5
HWC outlook and CRB pricing
Q (Mark Hughes · Truist): Analyst asked for more detail on Health, Wealth & Career (HWC) movement in the organic guide for Q4 and next year. He also asked whether pricing and growth differ between small/mid-market and large national accounts in CRB.
A: Management said HWC grew with Health strong, Wealth steady, Career had timing effects and BD&O was hit by three delayed implementations totaling 75,000 retirees that moved into next year. They now expect BD&O to be about flat for 2026, Health and Wealth to build momentum, Career to be limited by the Middle East, and the HWC segment to see low to mid-single-digit growth and margin expansion. On CRB pricing, they said large and complex accounts are most impacted by softening rates while the middle market is less affected.
"For the segment overall, we expect low to mid-single-digit growth and continued margin expansion for the full-year." — Julie Gebauer (PRESIDENT)
M&A focus and R&B organic growth
Q (Elyse Greenspan · Wells Fargo): Analyst asked what types, sizes, and geographies of inorganic deals WTW is considering and whether another transaction is likely soon. He also asked whether fourth-quarter R&B organic acceleration is versus the 5% reported or 4% ex book of business, and about 2027 outlook for the business.
A: Management said their M&A strategy is disciplined and focused on bolt-on deals that fit the specialty strategy, especially in wealth management and defined contribution, and they will selectively consider larger geographic opportunities. They said they are looking to increase their broking mix through M&A and see opportunities across the insurance value chain, including reinsurance. For R&B, they said R&B grew over 5% organic in the quarter and 4% ex book of business and investment income, and they expect Propel and technology investments to support margin expansion toward their R&B margin target by 2028.
"In thinking about direction, we're still looking to increase our business mix in broking through M&A." — Carl Hess (CEO)
Propel timing and reinsurance costs
Q (Gregory Peters · Raymond James): Analyst asked how the cadence of margin improvement from the Propel program might evolve now that deployment has begun. He also asked whether the BMS acquisition and reinsurance growth change expected reinsurance costs in the P&L next year.
A: Management said Propel's financial benefits ramp up in 2027 and compound into 2028, with free cash flow margin expanding in 2026 and further gains through 2028 and beyond; phasing varies by segment with HWC more even and R&B more weighted toward 2028. On Willis Re and BMS, they said the JV is progressing, BMS Re will close imminently, they are building the U.S. platform and scaling operations, and Willis Re will remain a drag on adjusted EPS next year as they invest and integrate BMS Re.
"The financial benefits ramp up from Propel in 2027 and compound into 2028." — Andrew Krasner (CFO)
Business links and margin sensitivity
Q (Paul Newsome · Piper Sandler): Analyst asked how connected slower-growing businesses (like BD&O) are to other parts of the company, and whether Wealth & Career help other segments or operate independently. He also asked how sensitive margin goals are to changes in organic growth over the next years.
A: Management said BD&O fits well inside HWC and can deepen client relationships by packaging benefits, technology, and administration, noting BD&O margins are above the enterprise margin and have expanded steadily. They also said many clients value combining broking/advisory with outsourcing to link workforce and claims data. Regarding margin sensitivity, they said their confidence in targets does not depend on one macro outcome but on actions they control and positioning across different external environments.
"To sum it up, I believe the strategic fit within HWC is strong." — Julie Gebauer (PRESIDENT)
R&B book settlements and CRB acceleration
Q (Michael Zaremski · BMO): Analyst asked what drove the acceleration in book of business revenues and whether the guidance for the year includes that in Q4. He also asked whether CRB's expected re-acceleration will come from Europe or other regions.
A: Management said producer movement and book of business settlements are normal; for the quarter they had $20 million of book of business settlements, with $18 million in R&B, and even excluding those settlements they saw solid underlying growth. On CRB acceleration, they said the quarter's 5% organic growth was driven by North America, EMEA, and Asia and they expect that growth to accelerate in the fourth quarter.
"For the quarter, we had $20 million of book of business settlements with $18 million in R&B." — Andrew Krasner (CFO)